Sugi Predict

Sugi Predict / Targets / TIPRL

TIPRL

TIP41-like protein · O75663 · TIPRL on Sugi Atlas →

0 patent compounds predicted against TIPRL, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TIPRL by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) PHASE2/PHASE3ACTIVE_NOT_RECRUITING
Danazol for Genetic Bone Marrow and Lung Disorders PHASE1/PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS) PHASE2COMPLETED
SCARFREE-001: Verteporfin for Scar Prevention PHASE2NOT_YET_RECRUITING
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas nanRECRUITING
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
New Signaling Pathway Targeting Systemic Lupus Erythematosus nanUNKNOWN
Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects nanWITHDRAWN
Elucidating the Molecular and Biochemical Basis of the Human AhR-mutation Disease nanUNKNOWN
Immune Cell Response to Stimuli nanRECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin nanCOMPLETED
Familial Partial Lipodystrophy Study nanCOMPLETED
Biological Signatures Resulting From Occupational Exposure to Complex Mixtures of PAHs nanUNKNOWN
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. nanUNKNOWN
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods nanUNKNOWN
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes nanCOMPLETED
Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH) nanWITHDRAWN
New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization nanCOMPLETED
Role of USP35 in the Detection of Ferroptosis in Juvenile Autoimmune Hepatitis nanNOT_YET_RECRUITING
Effect of Exercise on the Human Skeletal Muscle Phosphoproteome nanCOMPLETED
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome nanRECRUITING
Delineation of Novel Monogenic Disorders in the United Arab Emirates Population nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a TIPRL binder may also engage these)

ProteinNameSimilarity
A2AVJ0 — 0.999 A2AVJ0 →
Q20A00 — 0.999 Q20A00 →
Q8BH58 — 0.997 Q8BH58 →
Q5FW12 — 0.996 Q5FW12 →
Q5SD12 — 0.996 Q5SD12 →
Q04350 — 0.996 Q04350 →
P13742 — 0.995 P13742 →
Q809K1 — 0.995 Q809K1 →
A2VCX1 — 0.995 A2VCX1 →
Q8JTH1 — 0.995 Q8JTH1 →
P26658 — 0.995 P26658 →
Q6IRA8 — 0.995 Q6IRA8 →
Q24434 — 0.995 Q24434 →
P07051 — 0.995 P07051 →
P03104 — 0.994 P03104 →
J3TRC5 — 0.994 J3TRC5 →
Q38SQ2 — 0.994 Q38SQ2 →
Q9NY30 — 0.994 Q9NY30 →
Q66670 — 0.994 Q66670 →
Q809J9 — 0.994 Q809J9 →
Q95748 — 0.994 Q95748 →
Q2ICQ4 — 0.994 Q2ICQ4 →
Q25330 — 0.994 Q25330 →
C6Y4A2 — 0.994 C6Y4A2 →
Q5UQH7 — 0.994 Q5UQH7 →
Q9YTU2 — 0.994 Q9YTU2 →
P22046 — 0.993 P22046 →
P27208 — 0.993 P27208 →
Q01427 — 0.993 Q01427 →
Q6DNX9 — 0.993 Q6DNX9 →